MedPath

Ephedrine Sulfate

These highlights do not include all the information needed to use EPHEDRINE SULFATE INJECTION safely and effectively. See full prescribing information for EPHEDRINE SULFATE INJECTION. EPHEDRINE SULFATE Injection, for intravenous use Initial U.S. Approval: 2016

Approved
Approval ID

794cb942-04e3-4472-8eb8-92613329e4d5

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Sep 24, 2020

Manufacturers
FDA

Hikma Pharmaceuticals USA Inc.

DUNS: 946499746

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Ephedrine Sulfate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0641-6238
Application NumberANDA214334
Product Classification
M
Marketing Category
C73584
G
Generic Name
Ephedrine Sulfate
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateSeptember 24, 2020
FDA Product Classification

INGREDIENTS (4)

EPHEDRINE SULFATEActive
Quantity: 50 mg in 1 mL
Code: U6X61U5ZEG
Classification: ACTIB
ACETIC ACIDInactive
Code: Q40Q9N063P
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Ephedrine Sulfate - FDA Drug Approval Details